Theravance Biopharma, Inc. (TBPH)
13.96
-4.99
(-26.33%)
USD |
NASDAQ |
Mar 03, 16:00
13.70
-0.26
(-1.86%)
After-Hours: 20:00
Theravance Biopharma Price : 13.96 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Integer Holdings Corp. | 86.75 |
| QuidelOrtho Corp. | 21.48 |
| Corcept Therapeutics, Inc. | 35.28 |
| Nektar Therapeutics | 68.11 |
| Innoviva, Inc. | 22.30 |
Price Related Metrics
| PE Ratio | 24.82 |
| PS Ratio | 8.761 |
| Price to Book Value | 3.040 |
| Price to Free Cash Flow | 2.890 |
| Earnings Yield | 4.03% |
| Market Cap | 707.39M |
| Normalized PE Ratio | 24.82 |